JP2023022212A - ニコチン粉末消耗品物品 - Google Patents
ニコチン粉末消耗品物品 Download PDFInfo
- Publication number
- JP2023022212A JP2023022212A JP2022191027A JP2022191027A JP2023022212A JP 2023022212 A JP2023022212 A JP 2023022212A JP 2022191027 A JP2022191027 A JP 2022191027A JP 2022191027 A JP2022191027 A JP 2022191027A JP 2023022212 A JP2023022212 A JP 2023022212A
- Authority
- JP
- Japan
- Prior art keywords
- nicotine
- capsule
- consumable
- plug
- article
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 title claims abstract description 208
- 229960002715 nicotine Drugs 0.000 title claims abstract description 202
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 title claims abstract description 202
- 239000000843 powder Substances 0.000 title claims abstract description 149
- 239000002775 capsule Substances 0.000 claims abstract description 141
- 239000002245 particle Substances 0.000 claims abstract description 129
- 239000000463 material Substances 0.000 claims abstract description 47
- 239000011148 porous material Substances 0.000 claims abstract description 35
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- 238000004891 communication Methods 0.000 claims abstract description 9
- 239000000796 flavoring agent Substances 0.000 claims description 109
- 235000019634 flavors Nutrition 0.000 claims description 101
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 11
- 229960003136 leucine Drugs 0.000 claims description 6
- 239000004395 L-leucine Substances 0.000 claims description 5
- 235000019454 L-leucine Nutrition 0.000 claims description 5
- 229940024606 amino acid Drugs 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 229920002301 cellulose acetate Polymers 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 2
- 239000000123 paper Substances 0.000 claims description 2
- 239000011087 paperboard Substances 0.000 claims description 2
- BLUGYPPOFIHFJS-UUFHNPECSA-N (2s)-n-[(2s)-1-[[(3r,4s,5s)-3-methoxy-1-[(2s)-2-[(1r,2r)-1-methoxy-2-methyl-3-oxo-3-[[(1s)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]-3-methyl-2-(methylamino)butanamid Chemical compound CN[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)[C@H](OC)CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C=1SC=CN=1)CC1=CC=CC=C1 BLUGYPPOFIHFJS-UUFHNPECSA-N 0.000 claims 2
- 208000007934 ACTH-independent macronodular adrenal hyperplasia Diseases 0.000 claims 2
- 230000007246 mechanism Effects 0.000 description 19
- 230000000903 blocking effect Effects 0.000 description 16
- 150000001875 compounds Chemical class 0.000 description 14
- 230000001939 inductive effect Effects 0.000 description 12
- 210000004072 lung Anatomy 0.000 description 12
- 230000000391 smoking effect Effects 0.000 description 12
- 238000007789 sealing Methods 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 238000011144 upstream manufacturing Methods 0.000 description 8
- 235000019504 cigarettes Nutrition 0.000 description 7
- 235000013355 food flavoring agent Nutrition 0.000 description 7
- 230000002776 aggregation Effects 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000009472 formulation Methods 0.000 description 4
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 210000000214 mouth Anatomy 0.000 description 4
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 4
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 3
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 3
- 244000299461 Theobroma cacao Species 0.000 description 3
- 238000005054 agglomeration Methods 0.000 description 3
- -1 for example Substances 0.000 description 3
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 3
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229940041616 menthol Drugs 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 2
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 2
- JZBCTZLGKSYRSF-UHFFFAOYSA-N 2-Ethyl-3,5-dimethylpyrazine Chemical compound CCC1=NC=C(C)N=C1C JZBCTZLGKSYRSF-UHFFFAOYSA-N 0.000 description 2
- MMOPGICOOYBFJU-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;2-oxopropanoic acid Chemical compound CC(=O)C(O)=O.CN1CCCC1C1=CC=CN=C1 MMOPGICOOYBFJU-UHFFFAOYSA-N 0.000 description 2
- FFYVQVZXWDGRAY-UHFFFAOYSA-N 3-(1-methylpyrrolidin-2-yl)pyridine;hydrate Chemical compound O.CN1CCCC1C1=CC=CN=C1 FFYVQVZXWDGRAY-UHFFFAOYSA-N 0.000 description 2
- XPCTZQVDEJYUGT-UHFFFAOYSA-N 3-hydroxy-2-methyl-4-pyrone Chemical compound CC=1OC=CC(=O)C=1O XPCTZQVDEJYUGT-UHFFFAOYSA-N 0.000 description 2
- INAXVXBDKKUCGI-UHFFFAOYSA-N 4-hydroxy-2,5-dimethylfuran-3-one Chemical compound CC1OC(C)=C(O)C1=O INAXVXBDKKUCGI-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 244000024873 Mentha crispa Species 0.000 description 2
- 235000014749 Mentha crispa Nutrition 0.000 description 2
- 244000246386 Mentha pulegium Species 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 244000061176 Nicotiana tabacum Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 235000014676 Phragmites communis Nutrition 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- POIARNZEYGURDG-FNORWQNLSA-N beta-damascenone Chemical compound C\C=C\C(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-FNORWQNLSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 235000017803 cinnamon Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- CBOQJANXLMLOSS-UHFFFAOYSA-N ethyl vanillin Chemical group CCOC1=CC(C=O)=CC=C1O CBOQJANXLMLOSS-UHFFFAOYSA-N 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000008369 fruit flavor Substances 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- LHGVFZTZFXWLCP-UHFFFAOYSA-N guaiacol Chemical compound COC1=CC=CC=C1O LHGVFZTZFXWLCP-UHFFFAOYSA-N 0.000 description 2
- 230000001339 gustatory effect Effects 0.000 description 2
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229930007744 linalool Natural products 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- LDMPZNTVIGIREC-ZGPNLCEMSA-N nicotine bitartrate Chemical compound O.O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.OC(=O)[C@H](O)[C@@H](O)C(O)=O.CN1CCC[C@H]1C1=CC=CN=C1 LDMPZNTVIGIREC-ZGPNLCEMSA-N 0.000 description 2
- 229940069688 nicotine bitartrate Drugs 0.000 description 2
- DTUQWGWMVIHBKE-UHFFFAOYSA-N phenylacetaldehyde Chemical compound O=CCC1=CC=CC=C1 DTUQWGWMVIHBKE-UHFFFAOYSA-N 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 229940005605 valeric acid Drugs 0.000 description 2
- 229930007850 β-damascenone Natural products 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- WTOYNNBCKUYIKC-JMSVASOKSA-N (+)-nootkatone Chemical compound C1C[C@@H](C(C)=C)C[C@@]2(C)[C@H](C)CC(=O)C=C21 WTOYNNBCKUYIKC-JMSVASOKSA-N 0.000 description 1
- GKTOAHZEMRRUKF-HVDRVSQOSA-N (2s)-2-aminopentanedioic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound OC(=O)[C@@H](N)CCC(O)=O.CN1CCCC1C1=CC=CN=C1 GKTOAHZEMRRUKF-HVDRVSQOSA-N 0.000 description 1
- 229940098795 (3z)- 3-hexenyl acetate Drugs 0.000 description 1
- SKZDZXPBBYUFBY-WLHGVMLRSA-N (e)-but-2-enedioic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound OC(=O)\C=C\C(O)=O.CN1CCCC1C1=CC=CN=C1 SKZDZXPBBYUFBY-WLHGVMLRSA-N 0.000 description 1
- 239000001363 2-ethyl-3,5-dimethylpyrazine Substances 0.000 description 1
- AIBWPBUAKCMKNS-PPHPATTJSA-N 2-hydroxybenzoic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound OC(=O)C1=CC=CC=C1O.CN1CCC[C@H]1C1=CC=CN=C1 AIBWPBUAKCMKNS-PPHPATTJSA-N 0.000 description 1
- SDVKWBNZJFWIMO-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;3-(1-methylpyrrolidin-2-yl)pyridine Chemical compound CN1CCCC1C1=CC=CN=C1.OC(=O)CC(O)(C(O)=O)CC(O)=O SDVKWBNZJFWIMO-UHFFFAOYSA-N 0.000 description 1
- VWTHFJXLFGINSW-PPHPATTJSA-N 2-hydroxypropanoic acid;3-[(2s)-1-methylpyrrolidin-2-yl]pyridine Chemical compound CC(O)C(O)=O.CN1CCC[C@H]1C1=CC=CN=C1 VWTHFJXLFGINSW-PPHPATTJSA-N 0.000 description 1
- WLJVXDMOQOGPHL-PPJXEINESA-N 2-phenylacetic acid Chemical compound O[14C](=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-PPJXEINESA-N 0.000 description 1
- HDJBTCAJIMNXEW-PPHPATTJSA-N 3-[(2s)-1-methylpyrrolidin-2-yl]pyridine;hydrochloride Chemical compound Cl.CN1CCC[C@H]1C1=CC=CN=C1 HDJBTCAJIMNXEW-PPHPATTJSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 240000007154 Coffea arabica Species 0.000 description 1
- 244000004281 Eucalyptus maculata Species 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 241000208152 Geranium Species 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- HYMLWHLQFGRFIY-UHFFFAOYSA-N Maltol Natural products CC1OC=CC(=O)C1=O HYMLWHLQFGRFIY-UHFFFAOYSA-N 0.000 description 1
- YKVWPZJHENXDAJ-VOTSOKGWSA-N Megastigmatrienone Chemical compound CC1=CC(=O)CC(C)(C)C1\C=C\C=C YKVWPZJHENXDAJ-VOTSOKGWSA-N 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000009499 Vanilla fragrans Nutrition 0.000 description 1
- 244000263375 Vanilla tahitensis Species 0.000 description 1
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- POIARNZEYGURDG-UHFFFAOYSA-N beta-damascenone Natural products CC=CC(=O)C1=C(C)C=CCC1(C)C POIARNZEYGURDG-UHFFFAOYSA-N 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- NPFVOOAXDOBMCE-PLNGDYQASA-N cis-3-Hexenyl acetate Natural products CC\C=C/CCOC(C)=O NPFVOOAXDOBMCE-PLNGDYQASA-N 0.000 description 1
- RRGOKSYVAZDNKR-ARJAWSKDSA-M cis-3-hexenylacetate Chemical compound CC\C=C/CCCC([O-])=O RRGOKSYVAZDNKR-ARJAWSKDSA-M 0.000 description 1
- 239000001926 citrus aurantium l. subsp. bergamia wright et arn. oil Substances 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 235000016213 coffee Nutrition 0.000 description 1
- 235000013353 coffee beverage Nutrition 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000011246 composite particle Substances 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- WTOYNNBCKUYIKC-UHFFFAOYSA-N dl-nootkatone Natural products C1CC(C(C)=C)CC2(C)C(C)CC(=O)C=C21 WTOYNNBCKUYIKC-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 239000003571 electronic cigarette Substances 0.000 description 1
- 238000005538 encapsulation Methods 0.000 description 1
- 229940073505 ethyl vanillin Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 239000002657 fibrous material Substances 0.000 description 1
- 230000009969 flowable effect Effects 0.000 description 1
- 238000005243 fluidization Methods 0.000 description 1
- 238000002309 gasification Methods 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000010648 geranium oil Substances 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000010649 ginger oil Substances 0.000 description 1
- 229960001867 guaiacol Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 229940043353 maltol Drugs 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 235000014569 mints Nutrition 0.000 description 1
- 235000019575 mouthfulness Nutrition 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- HGBOYTHUEUWSSQ-UHFFFAOYSA-N pentanal Chemical compound CCCCC=O HGBOYTHUEUWSSQ-UHFFFAOYSA-N 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 229940100595 phenylacetaldehyde Drugs 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003216 pyrazines Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- PQDRXUSSKFWCFA-CFNZNRNTSA-N solanone Chemical compound CC(=O)CC[C@@H](C(C)C)\C=C\C(C)=C PQDRXUSSKFWCFA-CFNZNRNTSA-N 0.000 description 1
- PQDRXUSSKFWCFA-UHFFFAOYSA-N solanone Natural products CC(=O)CCC(C(C)C)C=CC(C)=C PQDRXUSSKFWCFA-UHFFFAOYSA-N 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- NPFVOOAXDOBMCE-UHFFFAOYSA-N trans-3-hexenyl acetate Natural products CCC=CCCOC(C)=O NPFVOOAXDOBMCE-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/10—Chemical features of tobacco products or tobacco substitutes
- A24B15/16—Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24B—MANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
- A24B15/00—Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
- A24B15/18—Treatment of tobacco products or tobacco substitutes
- A24B15/28—Treatment of tobacco products or tobacco substitutes by chemical substances
- A24B15/30—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
- A24B15/32—Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances by acyclic compounds
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/20—Devices using solid inhalable precursors
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/40—Constructional details, e.g. connection of cartridges and battery parts
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F40/00—Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
- A24F40/40—Constructional details, e.g. connection of cartridges and battery parts
- A24F40/42—Cartridges or containers for inhalable precursors
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
- A24F42/60—Constructional details
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F47/00—Smokers' requisites not otherwise provided for
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
- A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
- A61M15/0033—Details of the piercing or cutting means
- A61M15/0035—Piercing means
- A61M15/0036—Piercing means hollow piercing means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/06—Inhaling appliances shaped like cigars, cigarettes or pipes
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24F—SMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
- A24F42/00—Simulated smoking devices other than electrically operated; Component parts thereof; Manufacture or testing thereof
- A24F42/20—Devices without heating means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/06—Solids
- A61M2202/064—Powder
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Animal Behavior & Ethology (AREA)
- Anesthesiology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
【解決手段】ニコチン粉末消耗品物品200は、近位端204と遠位端206との間に延びる細長い消耗品本体201を含み、カプセル210は細長い消耗品本体内に固定される。細長い消耗品本体はカプセルに接触する。カプセルは、ニコチンまたはその薬学的に許容可能な塩を含む粒子215を含有する。第一の空気多孔性材料のプラグ224は、細長い消耗品本体内かつカプセルと近位端との間に配置され、第二の空気多孔性材料のプラグ226は、細長い消耗品本体内かつカプセルと遠位端との間に配置される。第二の空気多孔性材料のプラグは、第一の材料のプラグと気流連通していない。
【選択図】図1
Description
吸入器物品および吸入器システムについては、添付図面を参照しながら本発明をさらに説明するが、これは例証としてのみである。
Claims (14)
- ニコチンの粒子を送達するために吸入器物品で利用されるように構成されたニコチン粉末消耗品物品であって、
近位端と遠位端との間に延びる細長い消耗品本体と、
前記細長い消耗品本体内に固定された貫通可能なカプセルであって、前記細長い消耗品本体が前記貫通可能なカプセルと接触し、ニコチンまたはその薬学的に許容可能な塩を含む粒子を含有する、貫通可能なカプセルと、
前記細長い消耗品本体内かつ前記貫通可能なカプセルと前記近位端との間に配置される第一の材料のプラグと、
前記細長い消耗品本体内かつ前記貫通可能なカプセルと前記遠位端との間に配置される第二の空気多孔性材料のプラグであって、前記第一の材料のプラグと気流連通していない、第二の空気多孔性材料のプラグと、を備える、ニコチン粉末消耗品物品。 - 前記第二の空気多孔性材料のプラグが、前記細長い消耗品本体の遠位端によって画定される開放空間を完全に充填し、前記第一の材料のプラグが前記細長い消耗品本体の近位端によって画定される開放空間を完全に充填する、請求項1に記載のニコチン粉末消耗品物品。
- 前記第一の材料のプラグが、前記第二のプラグを形成する前記空気多孔性材料とは異なるタイプの材料である、請求項1または2に記載のニコチン粉末消耗品物品。
- 前記第一の材料のプラグが、酢酸セルロースを含む、請求項1または2に記載のニコチン粉末消耗品物品。
- 前記第二の空気多孔性材料のプラグが、酢酸セルロースを含む、請求項1~4のいずれかに記載のニコチン粉末消耗品物品。
- 前記細長い消耗品本体が、前記貫通可能なカプセルの周囲全体に直接接触し、前記貫通可能なカプセルを前記細長い消耗品本体に固定する、請求項1~5のいずれかに記載のニコチン粉末消耗品物品。
- 前記第一の材料のプラグまたは前記第二の空気多孔性材料のプラグ内に位置付けられた液体風味剤を含有する破裂可能な風味カプセルをさら含む、請求項1~6のいずれかに記載のニコチン粉末消耗品物品。
- 前記破裂可能な風味カプセルが、前記第二の多孔性材料のプラグ内に位置付けられる、請求項7に記載のニコチン粉末消耗品物品。
- ニコチンまたはその薬学的に許容可能な塩を含む前記粒子が、約1~約5マイクロメートルの範囲のMMAD粒子サイズを有する、請求項1~8のいずれかに記載のニコチン粉末消耗品物品。
- ニコチンまたは薬学的に許容可能な塩を含む粒子を含む前記粒子が、アミノ酸、好ましくはL-ロイシンを含む、請求項1~9のいずれかに記載のニコチン粉末消耗品物品。
- 前記カプセルが、約25マイクロメートルよりも大きく、または約50マイクロメートルよりも大きいMMAD粒子サイズを有する風味粒子をさらに含有する、請求項1~10のいずれかに記載のニコチン粉末消耗品物品。
- 前記細長い消耗品本体が、紙または板紙から形成される、請求項1~11のいずれかに記載のニコチン粉末消耗品物品。
- 前記細長い消耗品本体が内径値を有し、前記貫通可能なカプセルが外径値を有し、前記内径値と前記外径値とが実質的に同一の値である、請求項1~12のいずれかに記載のニコチン粉末消耗品物品。
- 前記細長い消耗品本体が、前記貫通可能なカプセルの長さの値の約400%~約200%の範囲の長さの値を有する、請求項1~13のいずれかに記載のニコチン粉末消耗品物品。
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP17173784 | 2017-05-31 | ||
EP17173784.4 | 2017-05-31 | ||
JP2019565227A JP7352471B2 (ja) | 2017-05-31 | 2018-05-22 | ニコチン粉末消耗品物品 |
PCT/IB2018/053620 WO2018220476A1 (en) | 2017-05-31 | 2018-05-22 | Nicotine powder consumable article |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019565227A Division JP7352471B2 (ja) | 2017-05-31 | 2018-05-22 | ニコチン粉末消耗品物品 |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2023022212A true JP2023022212A (ja) | 2023-02-14 |
Family
ID=59030769
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019565227A Active JP7352471B2 (ja) | 2017-05-31 | 2018-05-22 | ニコチン粉末消耗品物品 |
JP2022191027A Ceased JP2023022212A (ja) | 2017-05-31 | 2022-11-30 | ニコチン粉末消耗品物品 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019565227A Active JP7352471B2 (ja) | 2017-05-31 | 2018-05-22 | ニコチン粉末消耗品物品 |
Country Status (13)
Country | Link |
---|---|
US (1) | US11458263B2 (ja) |
EP (1) | EP3630243B1 (ja) |
JP (2) | JP7352471B2 (ja) |
KR (1) | KR102633996B1 (ja) |
CN (1) | CN110603068B (ja) |
BR (1) | BR112019022716A2 (ja) |
IL (1) | IL270587B2 (ja) |
MX (1) | MX2019014015A (ja) |
MY (1) | MY192983A (ja) |
PH (1) | PH12019502178B1 (ja) |
RU (1) | RU2768565C2 (ja) |
UA (1) | UA126153C2 (ja) |
WO (1) | WO2018220476A1 (ja) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02190178A (ja) * | 1989-01-19 | 1990-07-26 | Japan Tobacco Inc | 無煙たばこ |
JP2007520204A (ja) * | 2003-06-23 | 2007-07-26 | アール・ジエイ・レイノルズ・タバコ・カンパニー | 破壊可能なカプセルを組み込んだフィルタ付きシガレット |
JP2010511395A (ja) * | 2006-12-07 | 2010-04-15 | ブリティッシュ アメリカン タバコ (インヴェストメンツ) リミテッド | タバコ特有のニトロサミン類に選択性を有する分子インプリントポリマーおよびその使用方法 |
WO2015166350A2 (en) * | 2014-04-28 | 2015-11-05 | Philip Morris Products S.A. | Flavoured nicotine powder inhaler |
US20170071248A1 (en) * | 2015-09-16 | 2017-03-16 | Sansa Corporation (Barbados) Inc. | System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5067499A (en) * | 1984-09-14 | 1991-11-26 | R. J. Reynolds Tobacco Company | Smoking article |
US5052413A (en) | 1987-02-27 | 1991-10-01 | R. J. Reynolds Tobacco Company | Method for making a smoking article and components for use therein |
JPH022331A (ja) * | 1988-03-30 | 1990-01-08 | Kowa Display:Kk | 無煙煙草 |
US6883523B2 (en) * | 2003-02-14 | 2005-04-26 | Philip Morris Usa Inc. | Cigarette having porous heat transfer tube |
GB201200878D0 (en) * | 2012-01-19 | 2012-02-29 | British American Tobacco Co | Polymer compositions |
CA2963423C (en) * | 2007-03-30 | 2020-07-28 | Philip Morris Products S.A. | Device and method for delivery of a medicament |
WO2015101651A1 (en) | 2014-01-02 | 2015-07-09 | Philip Morris Products S.A. | Aerosol-generating system comprising a cylindrical polymeric capsule |
WO2015193498A1 (en) * | 2014-06-20 | 2015-12-23 | Philip Morris Products S.A. | Nicotine powder delivery system with airflow management means |
CN204861146U (zh) * | 2015-07-14 | 2015-12-16 | 广西中烟工业有限责任公司 | 一种具有可透视颗粒物的卷烟滤嘴 |
US20170055576A1 (en) * | 2015-08-31 | 2017-03-02 | R. J. Reynolds Tobacco Company | Smoking article |
CN113273731A (zh) * | 2015-12-24 | 2021-08-20 | 菲利普莫里斯生产公司 | 尼古丁粉末递送系统 |
CN105852223B (zh) | 2016-06-13 | 2019-02-12 | 广西中烟工业有限责任公司 | 一种非燃烧加热卷烟装置 |
-
2018
- 2018-05-22 WO PCT/IB2018/053620 patent/WO2018220476A1/en active Application Filing
- 2018-05-22 KR KR1020197033782A patent/KR102633996B1/ko active IP Right Grant
- 2018-05-22 CN CN201880030506.3A patent/CN110603068B/zh active Active
- 2018-05-22 UA UAA201910200A patent/UA126153C2/uk unknown
- 2018-05-22 MX MX2019014015A patent/MX2019014015A/es unknown
- 2018-05-22 JP JP2019565227A patent/JP7352471B2/ja active Active
- 2018-05-22 US US16/612,544 patent/US11458263B2/en active Active
- 2018-05-22 EP EP18729501.9A patent/EP3630243B1/en active Active
- 2018-05-22 BR BR112019022716-4A patent/BR112019022716A2/pt unknown
- 2018-05-22 RU RU2019143429A patent/RU2768565C2/ru active
- 2018-05-22 MY MYPI2019004393A patent/MY192983A/en unknown
-
2019
- 2019-09-23 PH PH12019502178A patent/PH12019502178B1/en unknown
- 2019-11-12 IL IL270587A patent/IL270587B2/en unknown
-
2022
- 2022-11-30 JP JP2022191027A patent/JP2023022212A/ja not_active Ceased
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02190178A (ja) * | 1989-01-19 | 1990-07-26 | Japan Tobacco Inc | 無煙たばこ |
JP2007520204A (ja) * | 2003-06-23 | 2007-07-26 | アール・ジエイ・レイノルズ・タバコ・カンパニー | 破壊可能なカプセルを組み込んだフィルタ付きシガレット |
JP2010511395A (ja) * | 2006-12-07 | 2010-04-15 | ブリティッシュ アメリカン タバコ (インヴェストメンツ) リミテッド | タバコ特有のニトロサミン類に選択性を有する分子インプリントポリマーおよびその使用方法 |
WO2015166350A2 (en) * | 2014-04-28 | 2015-11-05 | Philip Morris Products S.A. | Flavoured nicotine powder inhaler |
US20170071248A1 (en) * | 2015-09-16 | 2017-03-16 | Sansa Corporation (Barbados) Inc. | System and Method for Controlling the Harshness of Nicotine-Based Dry Powder Formulations |
Also Published As
Publication number | Publication date |
---|---|
EP3630243A1 (en) | 2020-04-08 |
RU2019143429A3 (ja) | 2021-09-06 |
MX2019014015A (es) | 2020-02-17 |
CN110603068A (zh) | 2019-12-20 |
UA126153C2 (uk) | 2022-08-25 |
KR102633996B1 (ko) | 2024-02-06 |
US20200196673A1 (en) | 2020-06-25 |
PH12019502178A1 (en) | 2020-06-08 |
JP7352471B2 (ja) | 2023-09-28 |
IL270587B1 (en) | 2023-01-01 |
IL270587A (ja) | 2019-12-31 |
BR112019022716A2 (pt) | 2020-05-12 |
PH12019502178B1 (en) | 2020-06-08 |
US11458263B2 (en) | 2022-10-04 |
RU2019143429A (ru) | 2021-06-30 |
IL270587B2 (en) | 2023-05-01 |
CN110603068B (zh) | 2022-05-03 |
WO2018220476A1 (en) | 2018-12-06 |
EP3630243B1 (en) | 2021-05-05 |
KR20200014283A (ko) | 2020-02-10 |
RU2768565C2 (ru) | 2022-03-24 |
MY192983A (en) | 2022-09-20 |
JP2020521555A (ja) | 2020-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7238043B2 (ja) | ニコチン粉末送達システム | |
JP6712232B2 (ja) | 風味付きニコチン粉末吸入器 | |
KR102494208B1 (ko) | 소용돌이 단부 플러그를 갖는 흡입기 | |
JP7183191B2 (ja) | 塞がれた気流要素を有する吸入器物品 | |
JP7249354B2 (ja) | 開口部付きの多孔性支持要素を備えた吸入器 | |
JP7242300B2 (ja) | ニコチン粒子カプセル | |
JP7356430B2 (ja) | 乾燥粉末吸入器 | |
KR102545359B1 (ko) | 맞춤 크기의 공동을 갖는 흡입기 | |
JP2019524061A (ja) | ニコチン粒子送達消耗品 | |
JP7352471B2 (ja) | ニコチン粉末消耗品物品 | |
RU2778721C2 (ru) | Ингалятор с вихревым каналом | |
RU2783884C2 (ru) | Ингалятор с вихревой полостью для капсулы | |
JP2023515007A (ja) | 風味要素を有する吸入器マウスピース |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20221213 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20221213 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230522 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20230802 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20230904 |
|
A045 | Written measure of dismissal of application [lapsed due to lack of payment] |
Free format text: JAPANESE INTERMEDIATE CODE: A045 Effective date: 20240129 |